Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114141742 | 11414174 | 2 | F | 20160620 | 20150824 | 20160701 | EXP | US-APOTEX-2015AP012231 | APOTEX | 21.00 | YR | M | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114141742 | 11414174 | 1 | PS | HALOPERIDOL. | HALOPERIDOL | 1 | Intravenous (not otherwise specified) | 5 MG, SINGLE | Y | 75440 | 5 | MG | INJECTION | 1X | |||||
| 114141742 | 11414174 | 2 | SS | OXYMORPHONE | OXYMORPHONE | 1 | Nasal | 10 MG, DAILY | 0 | 10 | MG | ||||||||
| 114141742 | 11414174 | 3 | SS | OXYMORPHONE | OXYMORPHONE | 1 | Oral | 10 MG DAILY | 0 | ||||||||||
| 114141742 | 11414174 | 4 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 1 MG AND THEN, SECOND DOSE OF 1 MG ON ICU DAY 5 | Y | 0 | |||||||||
| 114141742 | 11414174 | 5 | SS | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 114141742 | 11414174 | 6 | SS | OXYCODONE | OXYCODONE | 1 | Oral | OCCASIONALLY AND THEN PROGRESSED TO DAILY 60 MG | 0 | ||||||||||
| 114141742 | 11414174 | 7 | SS | OXYCODONE | OXYCODONE | 1 | Nasal | OCCASIONALLY AND THEN, PROGRESSED TO DAILY 60 MG | 0 | ||||||||||
| 114141742 | 11414174 | 8 | SS | DIAMORPHINE /00197602/ | DIACETYLMORPHINE HYDROCHLORIDE | 1 | Nasal | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114141742 | 11414174 | 1 | Delirium |
| 114141742 | 11414174 | 2 | Product used for unknown indication |
| 114141742 | 11414174 | 4 | Delirium |
| 114141742 | 11414174 | 5 | Product used for unknown indication |
| 114141742 | 11414174 | 6 | Product used for unknown indication |
| 114141742 | 11414174 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114141742 | 11414174 | OT |
| 114141742 | 11414174 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114141742 | 11414174 | Condition aggravated | |
| 114141742 | 11414174 | Delirium | |
| 114141742 | 11414174 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |